发明名称 |
COMBINATION THERAPY USING BUDESONIDE AND ANTISENSE OLIGONUCLEOTIDE TARGETED TO IL4-RECEPTOR ALPHA |
摘要 |
Provided herein is a method for reducing the amount of steroid required for the prevention, amelioration and/or treatment of pulmonary inflammation and/or airway hyperresponsiveness, comprisi administration of the steroid and an oligonucleotide targeted to IL-4R alpha. Also described is a method for the prevention, amelioration and/or treatment of pulmonary inflammation and/or airway hyperresponsiveness comprising administration of a corticosteroid and an oligonucleotide targeted to EL 4R alpha. Further provided are compositions comprising a corticosteroid and an EL-4R alpha targeted antisense oligonucleotide. |
申请公布号 |
WO2007041719(A3) |
申请公布日期 |
2007.06.21 |
申请号 |
WO2006US39168 |
申请日期 |
2006.10.03 |
申请人 |
ISIS PHARMACEUTICALS, INC.;KARRAS, JAMES, G.;GREGORY, SUSAN |
发明人 |
KARRAS, JAMES, G.;GREGORY, SUSAN |
分类号 |
C12Q1/68;A01N43/04;A61K38/00;C07H21/02;C07H21/04;C12N15/63;C12P19/34 |
主分类号 |
C12Q1/68 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|